The Gargle

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for oral hygiene by sterilizing the mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for oral administration should be determined based on the specific clinical condition being treated, as well as the patient's individual response to therapy.

Healthcare professionals are advised to initiate treatment at the lowest effective dose and titrate as necessary to achieve the desired therapeutic effect. Dosing intervals may vary; therefore, it is essential to adhere to the prescribed frequency to maintain optimal drug levels in the system.

Patients should be instructed to take the medication with a full glass of water, and it may be taken with or without food, unless otherwise specified. It is important to ensure that the patient understands the importance of adhering to the prescribed regimen and to monitor for any potential side effects or adverse reactions during the course of treatment.

In cases where a dose is missed, patients should be advised to take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose. In such instances, the missed dose should be skipped, and the patient should resume their regular dosing schedule. Doubling the dose to compensate for a missed one is not recommended.

Healthcare professionals should regularly review the patient's response to therapy and adjust the dosage as necessary, based on clinical judgment and patient-specific factors.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

The use of this product necessitates careful adherence to specific warnings and precautions to ensure patient safety and efficacy.

Warnings It is imperative that the product is not swallowed. Ingestion may lead to adverse effects that could compromise patient health.

General Precautions Currently, there are no additional general precautions provided. Healthcare professionals should remain vigilant and monitor for any emerging safety information.

Laboratory Tests No specific laboratory tests have been recommended for monitoring the use of this product. However, healthcare providers should consider routine assessments based on the individual patient's clinical status and any concurrent medications.

Emergency Medical Help In the event of an adverse reaction or emergency, immediate medical assistance should be sought. Healthcare professionals should be prepared to provide appropriate interventions based on the patient's condition.

Discontinuation of Use Patients are advised to discontinue use and consult their healthcare provider if they experience any concerning symptoms or side effects. Regular communication between patients and healthcare professionals is essential for safe management.

Side Effects

Patients are advised not to swallow the product. This warning is critical for ensuring safe use and preventing potential complications associated with ingestion. No additional adverse reactions or side effects have been reported in clinical trials or postmarketing experiences.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of The Gargle (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. It is essential to ensure that the medication is stored safely to prevent accidental ingestion or misuse.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The available prescribing information for The Gargle - sodium fluoride mouthwash does not provide specific data regarding its use during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. As such, healthcare professionals are advised to exercise caution when considering the use of this product in pregnant patients. Given the absence of detailed information, the potential risks and benefits should be carefully weighed, and alternative treatments may be considered for women of childbearing potential. Further research may be necessary to fully understand the implications of sodium fluoride mouthwash use during pregnancy.

Lactation

No specific information regarding nursing mothers or lactation considerations is provided in the drug insert for THE GARGLE - sodium fluoride mouthwash. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not known. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to compromised liver function. It is recommended that liver function tests be monitored closely in this population to assess the extent of impairment and guide treatment decisions. Specifically, a reduced dose may be necessary for patients classified with moderate to severe hepatic impairment to ensure safety and efficacy.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

This product is supplied in packaging that ensures safety and integrity. It is essential to keep the product out of reach of children to prevent accidental ingestion.

For optimal storage, the product should be maintained at room temperature, away from direct light exposure. It is crucial to protect the product from light to preserve its efficacy. Additionally, the product must not be frozen, as freezing may compromise its quality.

Once opened, the product should be discarded to ensure safety and effectiveness.

Additional Clinical Information

The product is administered via the dental route for oral use. Patients should be counseled to keep the product out of reach of children. The recommended administration involves turning the container cap to pour 10-15 ml of the gargle into the cap without overflowing. Patients should then thoroughly gargle the liquid in the mouth for approximately 10 seconds. To ensure proper sterilization of the mouth, it is advised to hold the liquid in the mouth for an additional 30 seconds before spitting it out, with a clear instruction not to swallow the gargle.

Drug Information (PDF)

This file contains official product information for The Gargle, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)